TRAW CIK: 1130598

Traws Pharma, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.5
FY22:
−16.3
FY23:
−17.9
FY24:
−29.8
FY25:
−18.2
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−0.01
FY24:
−3.65
FY25:
−2.59
Change from FY21 to FY25
millions USD
FY21:
55.6
FY22:
–
FY23:
–
FY24:
34.0
FY25:
3.20
millions USD
FY21:
36.0
FY22:
−16.3
FY23:
−17.9
FY24:
0.52
FY25:
−17.5
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−17.9
FY24:
−33.4
FY25:
−20.8

All amounts in millions USD Data source:SEC EDGAR